Each generation ushers in a unique perspective on how we work and live.
|
We are at a unique place in obesity care history where anti-obesity medications (AOMs) are showing promising, clinically significant weight loss for persons with obesity.
|
This presentation will provide an overview of the evidence basis for using continuous glucose monitoring (CGM) in patients with obesity.
|
The challenges of treating co-morbid binge eating disorder and obesity".
|
This session will focus on the management of non-alcoholic fatty liver disease (NAFLD) with a particular emphasis on the role of GLP-1 agonists and SGLT-2 inhibitors in treating this condition.
|
Weight stigma is an often-overlooked contributor to poor patient engagement and weight gain over time.
|
As the tools continue to advance in Obesity Medicine, it can be easy to overlook the importance of the Behavior pillar in treating obesity.
|
Social determinants of health, the conditions in the environments where people are born, live, learn, work, play, worship, and age, play a large role in how well patients can adhere to weight manag
|
In this session, Liz Paul will describe her experiences living with obesity, including her journey to overcoming internalized weight bias.
|
Physical activity is considered an important component of obesity treatment; however, the effect of physical activity on weight can be variable.
|